• Je něco špatně v tomto záznamu ?

Mid-trimester amniotic fluid proteome's association with spontaneous preterm delivery and gestational duration

M. Hallingström, P. Zedníková, V. Tambor, M. Barman, M. Vajrychová, J. Lenčo, F. Viklund, L. Tancred, H. Rabe, D. Jonsson, A. Kachikis, S. Nilsson, M. Kacerovský, KM. Adams Waldorf, B. Jacobsson,

. 2020 ; 15 (5) : e0232553. [pub] 20200507

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20025021

BACKGROUND: Amniotic fluid is clinically accessible via amniocentesis and its protein composition may correspond to birth timing. Early changes in the amniotic fluid proteome could therefore be associated with the subsequent development of spontaneous preterm delivery. OBJECTIVE: The main objective of this study was to perform unbiased proteomics analysis of the association between mid-trimester amniotic fluid proteome and spontaneous preterm delivery and gestational duration, respectively. A secondary objective was to validate and replicate the findings by enzyme-linked immunosorbent assay using a second independent cohort. METHODS: Women undergoing a mid-trimester genetic amniocentesis at Sahlgrenska University Hospital/Östra between September 2008 and September 2011 were enrolled in this study, designed in three analytical stages; 1) an unbiased proteomic discovery phase using LC-MS analysis of 22 women with subsequent spontaneous preterm delivery (cases) and 37 women who delivered at term (controls), 2) a validation phase of proteins of interest identified in stage 1, and 3) a replication phase of the proteins that passed validation using a second independent cohort consisting of 20 cases and 40 matched controls. RESULTS: Nine proteins were nominally significantly associated with both spontaneous preterm delivery and gestational duration, after adjustment for gestational age at sampling, but none of the proteins were significant after correction for multiple testing. Several of these proteins have previously been described as being associated with spontaneous PTD etiology and six of them were thus validated using enzyme linked immunosorbent assay. Two of the proteins passed validation; Neutrophil gelatinase-associated lipocalin and plasminogen activator inhibitor 1, but the results could not be replicated in a second cohort. CONCLUSIONS: Neutrophil gelatinase-associated lipocalin and Plasminogen activator inhibitor 1 are potential biomarkers of spontaneous preterm delivery and gestational duration but the findings could not be replicated. The negative findings are supported by the fact that none of the nine proteins from the exploratory phase were significant after correction for multiple testing.

Biomedical Research Center University Hospital Hradec Kralove Hradec Kralove Czech Republic

Biomedical Research Center University Hospital Hradec Kralove Hradec Kralove Czech Republic Department of Analytical Chemistry Faculty of Pharmacy Charles University Hradec Kralove Czech Republic

Biomedical Research Center University Hospital Hradec Kralove Hradec Kralove Czech Republic Department of Biological and Biochemical Science Faculty of Chemical Technology University of Pardubice Pardubice Czech Republic

Biomedical Research Center University Hospital Hradec Kralove Hradec Kralove Czech Republic Department of Molecular Pathology and Biology Faculty of Military Health Sciences University of Defense Hradec Kralove Czech Republic

Biomedical Research Center University Hospital Hradec Kralove Hradec Kralove Czech Republic Department of Obstetrics and Gynecology Charles University Prague Faculty of Medicine in Hradec Kralove Hradec Kralove Czech Republic

Department of Biology and Biological Engineering Food and Nutrition Science Chalmers University of Technology Gothenburg Sweden

Department of Infectious Diseases Institute of Biomedicine Sahlgrenska Academy University of Gothenburg Gothenburg Sweden

Department of Mathematical Sciences Chalmers University of Technology Gothenburg Sweden Department of Pathology and Genetics Institute of Biomedicine Sahlgrenska Academy University of Gothenburg Gothenburg Sweden

Department of Obstetrics and Gynecology Institute of Clinical Sciences Sahlgrenska Academy University of Gothenburg Gothenburg Sweden Biobank Väst Sahlgrenska University Hospital Gothenburg Sweden

Department of Obstetrics and Gynecology Institute of Clinical Sciences Sahlgrenska Academy University of Gothenburg Gothenburg Sweden Department of Obstetrics and Gynecology Sahlgrenska University Hospital Gothenburg Sweden

Department of Obstetrics and Gynecology Institute of Clinical Sciences Sahlgrenska Academy University of Gothenburg Gothenburg Sweden Department of Obstetrics and Gynecology Sahlgrenska University Hospital Gothenburg Sweden Department of Genetics and Bioinformatics Area of Health Data and Digitalisation Institute of Public Health Oslo Norway

Department of Obstetrics and Gynecology Institute of Clinical Sciences Sahlgrenska Academy University of Gothenburg Gothenburg Sweden Department of Obstetrics and Gynecology University of Washington Seattle Washington USA

Department of Obstetrics and Gynecology Sahlgrenska University Hospital Gothenburg Sweden Stockholm South General Hospital Stockholm Sweden

Department of Obstetrics and Gynecology University of Washington Seattle Washington USA

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025021
003      
CZ-PrNML
005      
20201222155016.0
007      
ta
008      
201125s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0232553 $2 doi
035    __
$a (PubMed)32379834
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hallingström, Maria $u Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg, Sweden.
245    10
$a Mid-trimester amniotic fluid proteome's association with spontaneous preterm delivery and gestational duration / $c M. Hallingström, P. Zedníková, V. Tambor, M. Barman, M. Vajrychová, J. Lenčo, F. Viklund, L. Tancred, H. Rabe, D. Jonsson, A. Kachikis, S. Nilsson, M. Kacerovský, KM. Adams Waldorf, B. Jacobsson,
520    9_
$a BACKGROUND: Amniotic fluid is clinically accessible via amniocentesis and its protein composition may correspond to birth timing. Early changes in the amniotic fluid proteome could therefore be associated with the subsequent development of spontaneous preterm delivery. OBJECTIVE: The main objective of this study was to perform unbiased proteomics analysis of the association between mid-trimester amniotic fluid proteome and spontaneous preterm delivery and gestational duration, respectively. A secondary objective was to validate and replicate the findings by enzyme-linked immunosorbent assay using a second independent cohort. METHODS: Women undergoing a mid-trimester genetic amniocentesis at Sahlgrenska University Hospital/Östra between September 2008 and September 2011 were enrolled in this study, designed in three analytical stages; 1) an unbiased proteomic discovery phase using LC-MS analysis of 22 women with subsequent spontaneous preterm delivery (cases) and 37 women who delivered at term (controls), 2) a validation phase of proteins of interest identified in stage 1, and 3) a replication phase of the proteins that passed validation using a second independent cohort consisting of 20 cases and 40 matched controls. RESULTS: Nine proteins were nominally significantly associated with both spontaneous preterm delivery and gestational duration, after adjustment for gestational age at sampling, but none of the proteins were significant after correction for multiple testing. Several of these proteins have previously been described as being associated with spontaneous PTD etiology and six of them were thus validated using enzyme linked immunosorbent assay. Two of the proteins passed validation; Neutrophil gelatinase-associated lipocalin and plasminogen activator inhibitor 1, but the results could not be replicated in a second cohort. CONCLUSIONS: Neutrophil gelatinase-associated lipocalin and Plasminogen activator inhibitor 1 are potential biomarkers of spontaneous preterm delivery and gestational duration but the findings could not be replicated. The negative findings are supported by the fact that none of the nine proteins from the exploratory phase were significant after correction for multiple testing.
650    _2
$a dospělí $7 D000328
650    _2
$a amniocentéza $7 D000649
650    _2
$a plodová voda $x chemie $x metabolismus $7 D000653
650    _2
$a kohortové studie $7 D015331
650    _2
$a ženské pohlaví $7 D005260
650    12
$a gestační stáří $7 D005865
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a těhotenství $7 D011247
650    _2
$a druhý trimestr těhotenství $x metabolismus $7 D011262
650    _2
$a předčasný porod $x metabolismus $7 D047928
650    _2
$a proteom $x analýza $7 D020543
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Zedníková, Petra $u Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic. Department of Biological and Biochemical Science, Faculty of Chemical Technology, University of Pardubice, Pardubice, Czech Republic.
700    1_
$a Tambor, Vojtěch $u Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Barman, Malin $u Department of Biology and Biological Engineering, Food and Nutrition Science, Chalmers University of Technology, Gothenburg, Sweden.
700    1_
$a Vajrychová, Marie $u Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic. Department of Molecular Pathology and Biology, Faculty of Military Health Sciences, University of Defense, Hradec Kralove, Czech Republic.
700    1_
$a Lenčo, Juraj $u Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic. Department of Analytical Chemistry, Faculty of Pharmacy, Charles University, Hradec Kralove, Czech Republic.
700    1_
$a Viklund, Felicia $u Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg, Sweden. Stockholm South General Hospital, Stockholm, Sweden.
700    1_
$a Tancred, Linda $u Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Biobank Väst, Sahlgrenska University Hospital, Gothenburg, Sweden.
700    1_
$a Rabe, Hardis $u Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
700    1_
$a Jonsson, Daniel $u Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg, Sweden.
700    1_
$a Kachikis, Alisa $u Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA.
700    1_
$a Nilsson, Staffan $u Department of Mathematical Sciences, Chalmers University of Technology, Gothenburg, Sweden. Department of Pathology and Genetics, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
700    1_
$a Kacerovský, Marian $u Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic. Department of Obstetrics and Gynecology, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Adams Waldorf, Kristina M $u Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA.
700    1_
$a Jacobsson, Bo $u Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg, Sweden. Department of Genetics and Bioinformatics, Area of Health Data and Digitalisation, Institute of Public Health, Oslo, Norway.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 15, č. 5 (2020), s. e0232553
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32379834 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222155012 $b ABA008
999    __
$a ok $b bmc $g 1599166 $s 1115707
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 15 $c 5 $d e0232553 $e 20200507 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...